Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cybin Inc. Common Stock

Cybin Inc. Common Stock (HELP) Stock Overview

Explore Cybin Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

HELP●NASDAQ
HealthcareMedical - Pharmaceuticals
$12.59
$0.12(0.96%)
U.S. Market opens in 43h 44m

Cybin Inc. Common Stock (HELP)

Meyka AI Score

Z

Key Financials

Market Cap780.4M
P/E Ratio-2.29
EPS (TTM)$-4.16
ROE-0.71%
Fundamental Analysis

AI Price Forecasts

1 Month$10.88
3 Months$11.85
1 Year Target$18.90

HELP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cybin Inc. Common Stock (NASDAQ: HELP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cybin Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HELP on the NASDAQ shows an RSI of 74.23, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $18.90 for the NASDAQ listing.

Key metrics behind Cybin Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -2.29 and a market capitalization of 780.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HELP on the NASDAQ.

Price Performance (NASDAQ: HELP)

1-Day Change
0.96%
5-Day Change
9.004%
1-Month Change
55.43%
3-Month Change
173.70%
6-Month Change
84.88%
Year-to-Date (YTD) Change
53.91%
1-Year Change
113.03%
3-Year Change
113.03%
5-Year Change
113.03%
All-Time (Max) Change
113.03%

Contact Information

https://www.helus.com
908 764 8385
100 King Street West, Toronto, ON, M5X 1C9

Company Facts

1,000 Employees
IPO DateSep 13, 2019
CountryCA
Actively Trading

Frequently Asked Questions